Health Condition 1: F320- Major depressive disorder, singleepisode, mild Health Condition 2: F321- Major depressive disorder, singleepisode, moderate Health Condition 3: F322- Major depressive disorder, singleepisode, severe without psychotic features
Conditions
Interventions
Intervention1: Magnesium supplementation: The data will be collected directly from the
subjects who are newly diagnosed with depression according to ICD 11. The depressive symptoms at
baseline will
Sponsors
Konaseema Institute of Medical sciences and research foundation
Eligibility
Inclusion criteria
Inclusion criteria: Subjects who are newly diagnosed with depression according to ICD 11
Exclusion criteria
Exclusion criteria: Patients who are on any other dietary supplement medication other than magnesium.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the effectiveness of magnesium as a supplement in alleviating the symptoms of depression.Timepoint: 2 time points Baseline At the end of 6 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the change in severity of depressive symptoms in patients diagnosed with depression with & without magnesium as a supplement along with the anti-depressant treatmentTimepoint: 2 time points Baseline At the end of 6 weeks | — |
Countries
India
Contacts
Public ContactMohammed Abdul salaam
Konaseema Institute of Medical Sciences and Reseach foundation
Outcome results
None listed